- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 13, 2026 | 495.76M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 461.71K sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 105.01K sh |
| Capex | Q1 2026 · Mar 31, 2026 | $1.33M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $171K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$51.3M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$6.66M |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $447.84M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $21.75M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.03B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $550.74M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.07B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $437.81M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $149.32M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $141.82M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.36B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $661.23M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.63B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $685.9M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $2.44B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.13B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.56 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.15 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.58 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.15 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $43.32M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $5.91M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $13.52M |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $3.46M |
| Net Income | Q1 2026 · Mar 31, 2026 | $362.8M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$14.14M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$42.67M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$10.31M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $24.66M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $1.49M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $25.46M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $2.76M |
| Revenue | Q1 2026 · Mar 31, 2026 | $50.12M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $4.25M |